Neuralgia
📧 Sign up to get email alerts when something new happens for Neuralgia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-02-06Clinical Trial Update: Effects of Pennsaid on Clinical Neuropathic Pain [NA]
This clinical trial update reports completion and posted results of a study evaluating Pennsaid for neuropathic pain conditions such as neur…
-
CLINICAL_TRIALS trial_result · 2016-11-08Clinical Trial Update: Novel Treatment Option for Neuropathic Pain [Phase 2]
Phase 2 clinical trial update for a novel treatment option targeting neuropathic pain. The study status is completed.
-
CLINICAL_TRIALS trial_result · 2016-07-11Clinical Trial Update: Influence of Dexmedetomidine and Lidocaine on Opioid Consumption in Laparoscopic Intestine Resection [Phase 4]
Phase 4 trial update assessing whether dexmedetomidine and lidocaine reduce postoperative opioid consumption in patients undergoing laparosc…
-
CLINICAL_TRIALS trial_result · 2016-03-22Clinical Trial Update: The Effect of Soy Protein on Neuropathic Pain [Phase 2]
Phase 2 trial evaluating soy protein for neuralgia has been terminated.
-
CLINICAL_TRIALS trial_result · 2016-02-09Clinical Trial Update: Examination of the Pathophysiologic Mechanisms of CRPS by Using QST, CPM, RIC, and Heart Rate Variability QST
A completed study from Ruhr University of Bochum examining the pathophysiology of Complex Regional Pain Syndrome using QST, CPM, remote isch…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-01-28Clinical Trial Update: Study to Evaluate the Efficacy of Lithium Carbonate in Spinal Cord Injury Patients With Neuropathic Pain [Phase 2]
A Phase 2 clinical trial evaluating lithium carbonate for neuropathic pain in spinal cord injury patients has completed.
-
EMA withdrawal · 2015-04-24EMA Application withdrawn: Duloxetine Sandoz (duloxetine) — Sandoz GmbH
EMA withdrawn application for Duloxetine Sandoz (duloxetine) by Sandoz GmbH.
-
CLINICAL_TRIALS trial_result · 2014-10-02Clinical Trial Update: A Study to Assess the Safety and Efficacy of 7 Days Treatment With a Novel Analgesic in Subjects With Peripheral Neuropathic Pain [Phase 2]
Phase 2 trial investigating safety and efficacy of a 7-day treatment with a novel analgesic for neuralgia was terminated with results posted…
-
CLINICAL_TRIALS trial_result · 2014-08-20Clinical Trial Update: Symptom Based Treatment of Neuropathic Pain [Phase 4]
Phase 4 clinical trial evaluating symptom-based treatment of neuropathic pain in neuralgia and spinal cord injury has completed.
-
CLINICAL_TRIALS trial_result · 2013-05-17Clinical Trial Update: An Open-Label Long-Term Study Of Pregabalin For The Treatment Of Central Neuropathic Pain [Phase 3]
Open-label long-term Phase 3 trial of pregabalin for central neuropathic pain due to spinal cord conditions completed; results posted in 201…
-
CLINICAL_TRIALS trial_result · 2012-01-19Clinical Trial Update: Safety and Efficacy of AGN201781 in Neuropathic Pain [Phase 2]
Allergan's AGN201781 in neuralgia (neuropathic pain) underwent a Phase 2 trial that was terminated. Results from the study were posted on 20…
-
CLINICAL_TRIALS trial_result · 2011-12-08Clinical Trial Update: A 17-Week Trial To Assess Pregabalin For The Treatment Of Nerve Pain Due To Spinal Cord Injury [Phase 3]
A Phase 3 trial assessing pregabalin for nerve pain due to spinal cord injury has completed with results posted in 2011.
-
CLINICAL_TRIALS trial_result · 2011-06-21Clinical Trial Update: Clinical Study With Lyrica In Patients Suffering From Epilepsy
Clinical study update for Lyrica in epilepsy patients; trial completed with results posted in 2011.
-
CLINICAL_TRIALS trial_result · 2011-05-17Clinical Trial Update: A Study of the Efficacy and Safety of Amitriptyline/Ketamine Topical Cream in Patients With Diabetic Peripheral Neuropathy [Phase 2]
Phase 2 study evaluating the efficacy and safety of amitriptyline/ketamine topical cream in diabetic peripheral neuropathy and neuralgia; re…
-
CLINICAL_TRIALS trial_result · 2011-03-23Clinical Trial Update: Evaluation of the Efficacy, Tolerability and Safety of Etoricoxib (Arcoxia) in Patients With Neuropathic Pain [Phase 4]
Phase 4 study evaluating the efficacy, tolerability and safety of etoricoxib (Arcoxia) in neuropathic pain, including postherpetic neuralgia…
-
CLINICAL_TRIALS trial_result · 2009-10-05Clinical Trial Update: P4 (Pregabalin for Peripheral Posttraumatic Pain) [Phase 4]
Phase 4 trial update for pregabalin in peripheral posttraumatic neuralgia (peripheral neuropathic pain) completed with results posted in 200…
-
CLINICAL_TRIALS research · 2009-07-24Clinical Trial Update: To Evaluate the Efficacy and Tolerability of the Use of Vitatonus Dexa Compared to Dexamethasone in Patients With Neuralgia of Various Origins [Phase 3]
Phase 3 trial comparing Vitatonus Dexa to dexamethasone in neuralgia; status is unknown and no results are reported in the document.
-
CLINICAL_TRIALS trial_result · 2009-03-13Clinical Trial Update: Pregabalin Peripheral Neuropathic Pain Study [Phase 3]
Phase 3 clinical trial update for pregabalin in peripheral neuropathic pain completed; results posted in 2009.
-
CLINICAL_TRIALS trial_result · 2009-02-23Clinical Trial Update: GW406381 In Patients With Peripheral Nerve Injury [Phase 1]
A Phase 1 trial of GW406381 in patients with peripheral nerve injury has completed. The study examined pain-related conditions such as hyper…
-
CLINICAL_TRIALS research · 2009-02-05Clinical Trial Update: Amitriptyline or Pregabalin to Treat Neuropathic Pain in Incurable Cancer [Phase 3]
Phase 3 clinical trial update evaluating amitriptyline or pregabalin for neuropathic pain in incurable cancer. The status is unknown.
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Dextromethorphan Versus Placebo for Neuropathic Pain [Phase 2]
A Phase 2 randomized trial comparing dextromethorphan to placebo for neuropathic pain in diabetic neuropathy, herpes zoster, and neuralgia w…
-
CLINICAL_TRIALS trial_result · 2007-06-13Clinical Trial Update: Efficacy of Valproate in Peripheral Neuropathic Pain [Phase 2, Phase 3]
A Phase 2/3 clinical trial evaluating valproate for neuralgia and peripheral neuropathic pain was terminated.